Zeons Corporation

Zeons Corporation

ZEON
Zeons CorporationUS flagOther OTC
0.00
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
Mathew Mark Zuckerman
Full Time Employees
4,493
Sector
Consumer Cyclical
Industry
Specialty Retail
Address
2961 W Macarthur Blvd Ste 131 Santa Ana CA United States of America 92704
IPO Date
Jul 16, 1997
Website
zeon.co.jp
Business
Zeon Corporation is a specialty chemicals and materials company headquartered in Tokyo, Japan, founded in 1950. It manufactures and sells synthetic elastomers including solution styrene butadiene rubber (S-SBR) and lithium-catalyzed butadiene rubber (Li-BR) used primarily in fuel-efficient tires; high-performance resins such as cyclo olefin polymers (COP) including ZEONEX® and ZEONOR® for optical, medical, and semiconductor applications; specialty chemicals including aroma chemicals, pharmaceutical and agrochemical intermediates, and industrial solvents; plastic films such as ZeonorFilm®; lithium-ion battery materials including sealants and binders; and medical products. The company operates globally with business activities spanning across 18 countries and 53 consolidated subsidiaries. Recent major changes include Zeon's acquisition of the US-based microfluidic prototype device manufacturer Edge Precision Manufacturing in late 2022 to accelerate its business development in healthcare and life sciences, targeting expansion into the US and European markets. Zeon merged its subsidiary ZS Elastomer Co., Ltd. in 2024 to consolidate resources and streamline operations following the dissolution of a joint venture with Sumitomo Chemical. In 2025, Zeon strengthened its supply system for advanced grades of S-SBR used in fuel-efficient tires by upgrading production equipment in Singapore. Additionally, Zeon is advancing a new cyclo olefin polymer production plant in Shunan City, Japan, with Mitsubishi Heavy Industries awarded the EPC contract for completion in 2028. These strategic moves align with Zeon's medium-term plan to grow new business areas including healthcare, mobility solutions, telecommunications, and energy conservation aiming for significant revenue increases by 2030. Zeon's business segments include elastomers, specialty materials, energy materials, and mobility solutions, serving industries such as automotive, electronics, telecommunications, construction, medical, and pharmaceuticals. The company maintains a diversified product portfolio and is focused on innovation and sustainability to meet global market needs. Its operations encompass manufacturing, research and development, and sales with a strong emphasis on high-value specialty chemical products and advanced materials. Zeon reported consolidated net sales of approximately 420.6 billion JPY and employs around 4,493 people as of 2025.

Company News

APIChat
  • Montauk Renewables (NASDAQ:MNTK) & Zeons (OTCMKTS:ZEON) Financial Contrast

  • GE Vernova (NYSE:GEV) versus Zeons (OTCMKTS:ZEON) Critical Analysis

  • Critical Survey: Zeons (OTCMKTS:ZEON) versus FuelCell Energy (NASDAQ:FCEL)

  • Zeons (OTCMKTS:ZEON) and Central Puerto (NYSE:CEPU) Financial Survey

  • Zeons (OTCMKTS:ZEON) and Cosan (NYSE:CSAN) Head-To-Head Comparison